Ruediger B. Müeller

1.4k total citations
45 papers, 1.0k citations indexed

About

Ruediger B. Müeller is a scholar working on Rheumatology, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, Ruediger B. Müeller has authored 45 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Rheumatology, 11 papers in Hematology and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Ruediger B. Müeller's work include Rheumatoid Arthritis Research and Therapies (30 papers), Systemic Lupus Erythematosus Research (15 papers) and Autoimmune and Inflammatory Disorders Research (11 papers). Ruediger B. Müeller is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (30 papers), Systemic Lupus Erythematosus Research (15 papers) and Autoimmune and Inflammatory Disorders Research (11 papers). Ruediger B. Müeller collaborates with scholars based in Switzerland, Germany and United States. Ruediger B. Müeller's co-authors include Philipp Rein, Martin Herrmann, Georg Schett, Johannes von Kempis, Gisela Ruiz‐Heiland, Axel Hempfing, Joachim Sieper, Joachim Listing, Heiner Appel and Jochen Zwerina and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Annals of the Rheumatic Diseases.

In The Last Decade

Ruediger B. Müeller

44 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruediger B. Müeller Switzerland 16 595 317 213 186 98 45 1.0k
Ana M. Ortiz Spain 19 459 0.8× 277 0.9× 347 1.6× 164 0.9× 168 1.7× 50 1.0k
So‐Young Bang South Korea 24 846 1.4× 593 1.9× 442 2.1× 128 0.7× 160 1.6× 100 1.8k
Toby Garrood United Kingdom 14 608 1.0× 420 1.3× 133 0.6× 287 1.5× 144 1.5× 36 1.1k
William Rich United States 8 422 0.7× 279 0.9× 182 0.9× 306 1.6× 159 1.6× 25 954
Sarah Bingham United Kingdom 16 545 0.9× 294 0.9× 104 0.5× 256 1.4× 104 1.1× 31 1.0k
Ronald J. Anderson United States 15 421 0.7× 183 0.6× 82 0.4× 98 0.5× 104 1.1× 28 857
Ji-Won Kim South Korea 15 210 0.4× 295 0.9× 198 0.9× 87 0.5× 42 0.4× 46 779
Eva Dokoupilová Czechia 23 1.3k 2.2× 1.5k 4.6× 130 0.6× 581 3.1× 187 1.9× 54 2.1k
Yasutaka Kimoto Japan 19 415 0.7× 572 1.8× 195 0.9× 118 0.6× 123 1.3× 62 1.2k
Ming‐Han Chen Taiwan 20 268 0.5× 249 0.8× 346 1.6× 85 0.5× 199 2.0× 66 1.1k

Countries citing papers authored by Ruediger B. Müeller

Since Specialization
Citations

This map shows the geographic impact of Ruediger B. Müeller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruediger B. Müeller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruediger B. Müeller more than expected).

Fields of papers citing papers by Ruediger B. Müeller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruediger B. Müeller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruediger B. Müeller. The network helps show where Ruediger B. Müeller may publish in the future.

Co-authorship network of co-authors of Ruediger B. Müeller

This figure shows the co-authorship network connecting the top 25 collaborators of Ruediger B. Müeller. A scholar is included among the top collaborators of Ruediger B. Müeller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruediger B. Müeller. Ruediger B. Müeller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brandt, Lena, Hendrik Schulze‐Koops, Thomas Hügle, et al.. (2024). Radiographic Progression in Patients with Rheumatoid Arthritis in Clinical Remission or Low Disease Activity: Results from a Swiss National Registry (SCQM). Journal of Clinical Medicine. 13(23). 7424–7424. 1 indexed citations
2.
Schulz, Martin, et al.. (2024). Does the Change of Weather Influence Disease Activity in Rheumatoid Arthritis Patients: Patients’ Self-Assessment via WebApp. Journal of Clinical Medicine. 13(17). 5336–5336. 1 indexed citations
3.
Gilbert, Benoît, Denis Mongin, Kim Lauper, et al.. (2024). Comparative effectiveness of baricitinib and alternative biological DMARDs in a Swiss cohort study of patients with RA. BMJ Open. 14(3). e072300–e072300. 3 indexed citations
4.
Avouac, Jérôme, Hubert Marotte, Alejandro Balsa, et al.. (2023). Teleconsultation in rheumatology: A literature review and opinion paper. Seminars in Arthritis and Rheumatism. 63. 152271–152271. 5 indexed citations
5.
Riek, Myriam, Almut Scherer, Burkhard Möller, et al.. (2023). Serious infection risk of tofacitinib compared to biologics in patients with rheumatoid arthritis treated in routine clinical care. Scientific Reports. 13(1). 17776–17776. 2 indexed citations
6.
Scherer, Almut, Andrea Rubbert‐Roth, Axel Finckh, et al.. (2022). Comparison of drug retention of TNF inhibitors, other biologics and JAK inhibitors in RA patients who discontinued JAK inhibitor therapy. Lara D. Veeken. 62(1). 89–97. 21 indexed citations
7.
Müeller, Ruediger B., Hendrik Schulze‐Koops, Daniel E. Furst, et al.. (2022). Effect of dose adjustments on the efficacy and safety of tofacitinib in patients with rheumatoid arthritis: a post hoc analysis of an open-label, long-term extension study (ORAL Sequel). Clinical Rheumatology. 41(4). 1045–1055. 3 indexed citations
8.
Semela, David, et al.. (2018). Improvement of primary biliary cholangitis (PBC) under treatment with sulfasalazine and abatacept. BMJ Case Reports. 2018. bcr–2018. 5 indexed citations
9.
Alpizar-Rodriguez, D., Laure Brulhart, Ruediger B. Müeller, et al.. (2017). The prevalence of anticitrullinated protein antibodies increases with age in healthy individuals at risk for rheumatoid arthritis. Clinical Rheumatology. 36(3). 677–682. 17 indexed citations
10.
11.
12.
Witt, M., Ruediger B. Müeller, Fabian Proft, et al.. (2016). Evaluation of a Novel Semi-Automated Ultrasound System for the Detection of Synovitis: A Prospective Study involving 45 Patients with Rheumatoid Arthritis. SHILAP Revista de lepidopterología. 2(4). E117–E123. 3 indexed citations
13.
14.
Müeller, Ruediger B., Axel Finckh, Sarah R. Haile, et al.. (2016). Does addition of glucocorticoids to the initial therapy influence the later course of the disease in patients with early RA? Results from the Swiss prospective observational registry (SCQM). Clinical Rheumatology. 36(1). 59–66. 13 indexed citations
15.
Schiff, Michael, Johannes von Kempis, Ronald Goldblum, John Tesser, & Ruediger B. Müeller. (2014). Rheumatoid arthritis secondary non-responders to TNF can attain an efficacious and safe response by switching to certolizumab pegol: a phase IV, randomised, multicentre, double-blind, 12-week study, followed by a 12-week open-label phase. Annals of the Rheumatic Diseases. 73(12). 2174–2177. 37 indexed citations
16.
Müeller, Ruediger B., Michael Schiff, Axel Finckh, et al.. (2014). The new 2010 ACR/EULAR criteria as predictor of clinical and radiographic response in patients with early arthritis. Clinical Rheumatology. 34(1). 51–59. 10 indexed citations
17.
Haslbeck, Martin, Matthias Englbrecht, Bettina Sehnert, et al.. (2010). Antibodies to the endoplasmic reticulum-resident chaperones calnexin, BiP and Grp94 in patients with rheumatoid arthritis and systemic lupus erythematosus. Lara D. Veeken. 49(12). 2255–2263. 35 indexed citations
18.
Müeller, Ruediger B., et al.. (2009). Increased expression of CD154 and FAS in SLE patients’ lymphocytes. Rheumatology International. 30(2). 181–185. 14 indexed citations
19.
Müeller, Ruediger B., Ahmed Sheriff, Udo S. Gaipl, Sebastian Wesselborg, & Kirsten Lauber. (2007). Attraction of phagocytes by apoptotic cells is mediated by lysophosphatidylcholine. Autoimmunity. 40(4). 342–344. 51 indexed citations
20.
Stechow, D. von, et al.. (2001). TRANCE/RANKL knockout mice are protected from bone erosion in the K/BxN serum transfer model of arthritis. Queensland's institutional digital repository (The University of Queensland). 44. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ana M. Ortiz Breakdown of academic impact, for papers by So‐Young Bang Breakdown of academic impact, for papers by Toby Garrood Breakdown of academic impact, for papers by William Rich Breakdown of academic impact, for papers by Sarah Bingham Breakdown of academic impact, for papers by Ronald J. Anderson Breakdown of academic impact, for papers by Ji-Won Kim Breakdown of academic impact, for papers by Eva Dokoupilová Breakdown of academic impact, for papers by Yasutaka Kimoto Breakdown of academic impact, for papers by Ming‐Han Chen
Rankless by CCL
2026